Results 161 to 170 of about 175,728,522 (204)
Some of the next articles are maybe not open access.
Predicting the depth of superficial adenocarcinoma of the esophagogastric junction
Journal of Gastroenterology and Hepatology, 2021AbstractBackground and AimPreoperative determination of the invasion depth of superficial adenocarcinoma of the esophagogastric junction is important for appropriate endoscopic or surgical resection. There are no objective criteria regarding this; therefore, we investigated the factors associated with the invasion depth of superficial adenocarcinoma of
Kazunori Takada +13 more
openaire +2 more sources
Epidemiology of Adenocarcinoma of the Esophagogastric Junction
Surgical Oncology Clinics of North America, 2006The incidence of adenocarcinoma of the esophagogastric junction has increased rapidly in the later half of the twentieth century in the United States and most western countries. Although squamous cell carcinoma of the esophagus used to predominate, adenocarcinoma of the distal esophagus and esophagogastric junction now accounts for more than half of ...
Scott, Keeney, Thomas L, Bauer
openaire +2 more sources
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus
Gastroenterology, 1995Barrett's esophagus is associated with adenocarcinoma of the esophagus. The aim of this study was to find the prevalence of Barrett's esophagus in patients with adenocarcinoma of the esophagogastric junction.Consecutive, freshly resected surgical esophagogastrectomy specimens were examined, and multiple histological sections were made around the tumor ...
A J, Cameron +3 more
openaire +2 more sources
Adenocarcinoma of the Esophagogastric Junction
2017Esophagogastric junction (EGJ) cancer is, among solid cancers, the fastest growing tumor in terms of incidence in Western countries, and due to the lifestyle changes in developing and newly industrialized countries, this trend is expected to intensify worldwide.
GIACOPUZZI, Simone +2 more
openaire +2 more sources
Surgical Strategies for Adenocarcinoma of the Esophagogastric Junction
2009This chapter summarizes the surgical strategies for adenocarcinomas of the distal esophagus, gastric cardia, and subcardial gastric cancer invading the cardia+/-distal esophagus known as adenocarcinomas of the esophagogastric junction (AEG). The different surgical approaches according to the tumor origin, localization, and tumor stage are addressed ...
Schiesser, M, Schneider, P M
openaire +3 more sources
Sentinel Node Mapping in Adenocarcinoma of the Esophagogastric Junction
World Journal of Surgery, 2014AbstractBackgroundThe incidence of adenocarcinoma of the esophagogastric junction (AEG) is increasing, but the surgical strategy for AEG remains controversial. We hypothesized that sentinel node (SN) mapping for AEG could be validated to avoid unnecessary lymphadenectomy and permit minimally invasive surgery.
Tatsuo, Matsuda +5 more
openaire +2 more sources
Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction
Journal of Surgical Oncology, 2005AbstractDuring the last few decades there has been an alarming rise in the incidence of tumors originating at the esophagogastric junction (EGJ) [1]. The reason for this is unknown. Tumors of the EGJ can be categorized in two types of cancer divided according to their anatomical origin: distal esophageal adenocarcinoma and adenocarcinoma of the gastric
Marsman, W. A. +3 more
openaire +3 more sources
Clinical Staging of Adenocarcinoma of the Esophagogastric Junction
2009Tumors of the esophagogastric junction are among the most frequent and cause lethal cancers. Patients often do not present until late in the disease when the tumor is sufficiently large to cause obstruction or invasion of the adjacent structures, and thus becomes symptomatic.
Julia, Cordin +2 more
openaire +2 more sources
Localized adenocarcinoma of the esophagogastric junction – Is there a standard of care?
Cancer Treatment Reviews, 2010Adenocarcinoma of the esophagogastric junction (AEG) is the most rapidly increasing tumour in the Western world. Most patients present with locally advanced resectable disease and treatment can be curative. However, no accepted standard treatment exists. Cancer specialists frequently differ on optimum treatment strategies.
D G, Power, J V, Reynolds
openaire +2 more sources
Is There a Role For PET/CT With Esophagogastric Junction Adenocarcinoma?
Clinical Nuclear Medicine, 2015The value of 18F-FDG PET/CT in the initial diagnosis and in the locoregional staging of esophagogastric junction adenocarcinoma is not fully established. However, 18F-FDG PET/CT is widely accepted as the best modality for identification of suspected metastases in staging of the disease.
David, Fuster +7 more
openaire +2 more sources

